LATEST ALERTS
Japan Tobacco International (JTI) has reported increases in sales of reduced-risk products, helping offset falling shipment volumes of combustible tobacco products
Altria saw $12.43bn in revenue in the first half of 2022 – a decrease of 4.1% from the same period a year ago – but was encouraged by the positive momentum of its nicotine pouch brand On!
British American Tobacco (BAT) saw revenue from its new products category portfolio rise by 45% in the first half of the year, with good returns from its modern oral and heated tobacco portfolio
Swedish Match has reported a 17% sales increase in the first half of the year, driven by smoke-free products, with solid growth for its Zyn nicotine pouches in both the US and Scandinavian markets
Philip Morris International (PMI) has raised its full year outlook after it saw decent numbers over the first half of 2022
22nd Century Group has confirmed the first international shipments of very low nicotine (VLN) cigarettes to South Korea and is expecting to see significant benefits from the sales of its menthol line of VLN cigarettes as it plans an expansion of sales and distribution in the US beyond its initial trial in Chicago, Illinois
Germany is one of the leading heat-not-burn (HnB) markets in the world, and is the country with the fifth largest market size globally according to TobaccoIntelligence’s database. This report presents the most important findings from a survey we conducted in the first quarter of 2022
Most tobacco companies are keen to be seen supporting the concept of harm reduction, especially through reduced-risk products like e-cigarettes, heat-not-burn and pouches. But how far is their support for the idea actually having an effect on their activities right now, as well as their future direction?
On 13th April 2022 the Belgian Competition Authority’s decision-making body, the Competition College, imposed fines totalling €36m on four major cigarette manufacturers for practices that restricted competition
Swedish Match saw its smoke-free portfolio continuing to drive sales as well as increase operating profits in the first quarter of 2022, compared with the same period in 2021, and attributed this positive performance to “strong momentum for the US smoke-free business”
The $16bn takeover of Swedish Match by Philip Morris International (PMI) now seems more likely to happen than not (at least as of today; these things are never certain until the last signature is signed)
The board of Swedish Match has asked shareholders of the Scandinavian nicotine pouch maker to accept a $16bn takeover offer from tobacco giant Philip Morris International (PMI)
Philip Morris International (PMI) is in talks to buy European rival Swedish Match in an estimated $15bn deal that could affect both the oral and smoking tobacco markets
Altria saw $5.9bn in revenue in Q1 2022 – a decrease from both Q4 2021 ($6.25bn) and by 2.4% compared to Q1 2021
Japan Tobacco International (JTI) saw its revenues increase by 6.2% to JPY581.5bn ($4.5bn) in the first quarter of 2022, despite uncertainties over its business in Russia, compared with 5.3% growth to JPY547.3bn ($4.2bn) in the same period of 2021
Philip Morris International (PMI) saw positive numbers for the first quarter of 2022, with Iqos Iluma performing well in Japan, Switzerland and Spain
A reply from Los Angeles County lawyers is expected soon, after RJ Reynolds Tobacco Company and two other tobacco companies asked a federal appellate court to review its earlier affirmation of the county’s ban on flavoured tobacco sales
British American Tobacco (BAT) has invested a further CAD6.3m (USD5.03m) in the Canadian cannabis company Organigram, thereby increasing its stake from 18.8% to 19.5%
Philip Morris International (PMI) has cancelled all product launches in Russia for 2022 as part of its plans to suspend investments and scale down manufacturing operations across the country
The US Food and Drug Administration (FDA) has authorised the marketing of Logic Technology Development’s heated tobacco product Vapeleaf
Imperial Brands has announced that it is suspending all operations in Russia, including domestic production, and all sales and marketing activity as a result of international sanctions and the consequential severe disruption
US company 22nd Century reports its full-year results for 2021, with a company loss but increased net sales, and plans for expansion for its VLN cigarettes both domestically and internationally
British American Tobacco (BAT) saw revenue from its new products category portfolio rise by 42.4% in 2021 to £2.05bn, driven in part by an increase in sales of its modern oral products
Japan Tobacco International (JTI) will look to prioritise heated tobacco as part of its commitment to break even on its reduced risk portfolio (RRP) by 2027
Philip Morris International (PMI) posted positive numbers for 2021, helped by higher unit volumes in heated tobacco and outstanding initial results from its fourth-generation heated tobacco device Iqos Iluma
Approval of applications to sell new nicotine products in Norway appears to be a difficult proposition, according to Swedish Match, which had its application for an oral nicotine pouch rejected
Tobacco giant Altria’s net revenues slightly declined in 2021, partially offset by growth in the company’s oral tobacco products segment
Philip Morris’s bid to resume importing and selling its Iqos heat-not-burn (HnB) device in the US has failed
2021 may have been a downer in many other areas but the year saw phenomenal growth across tobacco alternatives, including in the oral segment, heated tobacco and nicotine pouches
The US FDA’s marketing authorisation of two low-nicotine cigarettes as modified risk tobacco products – including a menthol cigarette – has not gone down well with public health associations or all harm reduction experts
It’s the end of an era as tobacco sponsorship of Formula One racing comes to an end – again. Or does it and is it?
Tobacco giant Imperial Brands has told investors that the ongoing trials of its Pulze heated tobacco device and iD consumables in Central and Eastern Europe were “progressing well”
Altria posted a 4.7% revenue decline in the third quarter of the year, mainly driven by the continuing poor performance of its smokable segment but neutralised by the growth of its oral products in the US
The US Food and Drug Administration (FDA) has issued marketing authorisation for four mint-flavoured oral tobacco products that were withdrawn from the US market in 2019
Tobacco corporations seem to be accelerating their commitment towards more sustainable businesses, investing in projects to reduce environmental harm caused by tobacco-alternative devices
Philip Morris International (PMI) has concluded its controversial £1.1bn takeover of UK health firm Vectura, along with that of the Danish oral-products manufacturer Fertin Pharma
Swedish Match has announced that the company is to become 100% smoke-free by next year with the separation of its cigar business in the US, a decision that is likely to have an impact in the market
The board of UK health firm Vectura has recommended that shareholders support the £1.2bn takeover bid from tobacco giant PMI
The proposal of Philip Morris International (PMI) to acquire inhaled drug delivery company Ventura for $1.2bn has alerted the UK government, which can block the deal if it sees any major public interest reason to do so
JTI posted positive numbers in the first half of the year, with good performance from its reduced-risk products and improvement in its full-year guidance after the launch of Ploom X
Jacek Olczak, CEO of Philip Morris International (PMI), says the company could stop selling combustible cigarettes in the UK within a decade
British American Tobacco (BAT) has posted a 0.8% global decrease in revenue for the first half of the year, while the performance of its new category portfolio rose by 40.4%
The latest figures from Swedish Match show continued momentum in smoke-free tobacco alternatives, with nicotine pouches “the driving force”
Philip Morris International (PMI) has always been one of the frankest tobacco companies when it comes to speaking of the smoke-free future – now it is taking positive steps in a bold new direction
PMI’s acquisition of Fertin Pharma, a Danish manufacturer of gums and other oral products, indicates the company’s strategy to ensure “corporate survival” in the tobacco-alternatives sector, experts believe
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of FREE platform access: Demo our data contents without commitment
"*" indicates required fields
